MAGEA12 Antikörper (AA 121-210)
Kurzübersicht für MAGEA12 Antikörper (AA 121-210) (ABIN721300)
Target
Alle MAGEA12 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 121-210
-
Kreuzreaktivität
- Human
-
Aufreinigung
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human MAGEA12
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
ELISA 1:500-1000
IHC-P 1:200-400
IHC-F 1:100-500
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 μg/μL
-
Buffer
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
-
Haltbarkeit
- 12 months
-
-
- MAGEA12 (Melanoma Antigen Family A, 12 (MAGEA12))
-
Andere Bezeichnung
- MAGEA12
-
Hintergrund
-
Synonyms: Cancer/testis antigen 1.12, Cancer/testis antigen family 1 member 12, CT1.12, MAGAC_HUMAN, MAGE 12 antigen, MAGE-12 antigen, MAGE12, MAGE12 antigen, MAGE12F, MAGE12F antigen, MAGEA12, Melanoma antigen family A 12, Melanoma associated antigen 12, Melanoma-associated antigen 12.
Background: Not known, though may play a role in tumor transformation or aspects of tumor progression.Tissue specificity: Expressed in many tumors of several types, such as melanoma, head and neck squamous cell carcinoma, lung carcinoma and breast carcinoma, but not in normal tissues except for testes.
-
Gen-ID
- 4111
Target
-